110
Participants
Start Date
April 7, 2025
Primary Completion Date
September 21, 2026
Study Completion Date
October 21, 2026
CardiolRx
The intervention will be administered orally (via syringe) with food twice daily.
RECRUITING
NYU Langone Health, New York
RECRUITING
Columbia University - New York Presbyterian, New York
RECRUITING
Columbia University - New York Presbyterian, New York
RECRUITING
Lenox Hill Hospital, New York
NOT_YET_RECRUITING
MedStar Health Institute, Columbia
NOT_YET_RECRUITING
Johns Hopkins University, Baltimore
RECRUITING
University of Virginia, Charlottesville
RECRUITING
Virginia Commonwealth University, Richmond
RECRUITING
Mayo Clinic Florida, Jacksonville
RECRUITING
Mayo Clinic, Jacksonville
RECRUITING
Cleveland Clinic, Cleveland
NOT_YET_RECRUITING
Minneapolis Heart Institute, Minneapolis
RECRUITING
Mayo Clinic, Rochester
RECRUITING
Northwestern University, Chicago
RECRUITING
Houston Methodist Hospital, Houston
NOT_YET_RECRUITING
University of Utah Hospital, Salt Lake City
RECRUITING
Mayo Clionic Arizona, Phoenix
NOT_YET_RECRUITING
UCI Health, Irvine
RECRUITING
Massachusetts General Hospital, Boston
RECRUITING
University of Vermont, Burlington
RECRUITING
Jewish General Hospital, Montreal
RECRUITING
Hippokration General Hospital, Athens
NOT_YET_RECRUITING
Fatebenefratelli Hospital Milano, Milan
NOT_YET_RECRUITING
University of Padua, Padua
NOT_YET_RECRUITING
University Hospital, Torino
NOT_YET_RECRUITING
University Hospital Udine, Udine
Lead Sponsor
Cardiol Therapeutics Inc.
INDUSTRY